JP2010536719A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536719A5
JP2010536719A5 JP2010520440A JP2010520440A JP2010536719A5 JP 2010536719 A5 JP2010536719 A5 JP 2010536719A5 JP 2010520440 A JP2010520440 A JP 2010520440A JP 2010520440 A JP2010520440 A JP 2010520440A JP 2010536719 A5 JP2010536719 A5 JP 2010536719A5
Authority
JP
Japan
Prior art keywords
tumors
group
leukemia
head
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010520440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536719A (ja
Filing date
Publication date
Priority claimed from DE102007038957A external-priority patent/DE102007038957A1/de
Application filed filed Critical
Publication of JP2010536719A publication Critical patent/JP2010536719A/ja
Publication of JP2010536719A5 publication Critical patent/JP2010536719A5/ja
Pending legal-status Critical Current

Links

JP2010520440A 2007-08-17 2008-07-18 ６−チオキソピリダジン誘導体 Pending JP2010536719A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007038957A DE102007038957A1 (de) 2007-08-17 2007-08-17 6-Thioxo-pyridazinderivate
PCT/EP2008/005928 WO2009024221A1 (de) 2007-08-17 2008-07-18 6-thioxo-pyridazinderivate

Publications (2)

Publication Number Publication Date
JP2010536719A JP2010536719A (ja) 2010-12-02
JP2010536719A5 true JP2010536719A5 (cg-RX-API-DMAC7.html) 2011-09-08

Family

ID=40029265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520440A Pending JP2010536719A (ja) 2007-08-17 2008-07-18 ６−チオキソピリダジン誘導体

Country Status (7)

Country Link
US (1) US20110136819A1 (cg-RX-API-DMAC7.html)
EP (1) EP2176236A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010536719A (cg-RX-API-DMAC7.html)
AU (1) AU2008290896A1 (cg-RX-API-DMAC7.html)
CA (1) CA2696472A1 (cg-RX-API-DMAC7.html)
DE (1) DE102007038957A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009024221A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
WO2012003338A1 (en) 2010-07-01 2012-01-05 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
WO2012030633A1 (en) * 2010-08-31 2012-03-08 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
HRP20200854T1 (hr) 2013-06-21 2020-08-21 Zenith Epigenetics Ltd. Novi biciklički inhibitori bromodomene
WO2015004534A2 (en) 2013-06-21 2015-01-15 Zenith Epigenetics Corp. Novel substituted bicyclic compounds as bromodomain inhibitors
JP6542212B2 (ja) 2013-07-31 2019-07-10 ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． ブロモドメイン阻害剤としての新規キナゾリノン
US10710992B2 (en) 2014-12-01 2020-07-14 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
US10179125B2 (en) 2014-12-01 2019-01-15 Zenith Epigenetics Ltd. Substituted pyridines as bromodomain inhibitors
JP6864953B2 (ja) 2014-12-09 2021-04-28 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ａｘｌに対するヒトモノクローナル抗体
US10292968B2 (en) 2014-12-11 2019-05-21 Zenith Epigenetics Ltd. Substituted heterocycles as bromodomain inhibitors
WO2016097863A1 (en) 2014-12-17 2016-06-23 Zenith Epigenetics Corp. Inhibitors of bromodomains
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis
DK3877052T3 (da) 2018-11-06 2023-09-25 Edgewise Therapeutics Inc Pyridazinonforbindelser og anvendelser deraf
CN113272280A (zh) 2018-11-06 2021-08-17 艾知怀斯治疗学公司 哒嗪酮化合物及其用途
SG11202104713RA (en) 2018-11-06 2021-06-29 Edgewise Therapeutics Inc Pyridazinone compounds and uses thereof
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
CA3256897A1 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for the administration of nucleic acids and their methods of use
CN116768868B (zh) * 2023-08-15 2023-12-08 云南省药物研究所 一种哒嗪酮硫代衍生物及其制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US817363A (en) * 1905-12-11 1906-04-10 Hugh B Cunningham Pipe-pulling jack.
JPS5795964A (en) 1980-12-04 1982-06-15 Morishita Seiyaku Kk Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en) 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
AU691673B2 (en) 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
US5635494A (en) 1995-04-21 1997-06-03 Rohm And Haas Company Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
KR100489174B1 (ko) 1996-03-05 2005-09-30 제네카-파마 소시에떼아노님 4-아닐리노퀴나졸린유도체
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
BR9813998A (pt) * 1997-11-19 2000-09-26 Kowa Co Novos derivados de piridazina e produtos medicinais contendo os mesmos como ingredientes efetivos
TWI241295B (en) * 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6242461B1 (en) * 2000-01-25 2001-06-05 Pfizer Inc. Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
AU2001258628A1 (en) 2000-05-31 2001-12-11 Astrazeneca Ab Indole derivatives with vascular damaging activity
NZ522861A (en) 2000-07-07 2004-07-30 Angiogene Pharm Ltd Colchinol derivatives as vascular damaging agents
JP2004504391A (ja) 2000-07-07 2004-02-12 アンギオジェン・ファーマシューティカルズ・リミテッド 血管新生阻害剤としてのコルキノール誘導体
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
MXPA05006568A (es) * 2002-12-20 2005-09-22 Pharmacia Corp Compuestos de pirazol aciclico para la inhibicion de proteina cinasa-2 activada por proteina cinasa activada por mitogenos.
ES2349041T3 (es) 2004-07-16 2010-12-22 Schering Corporation Derivados de hidantoina para el tratamiento de trastornos inflamatorios.
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
ES2612377T3 (es) * 2005-12-21 2017-05-16 Janssen Pharmaceutica N.V. Triazolopiridazinas como moduladores de tirosina cinasas
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
PE20080403A1 (es) * 2006-07-14 2008-04-25 Amgen Inc Derivados heterociclicos fusionados y metodos de uso
DE102007026341A1 (de) * 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
WO2009057827A1 (en) * 2007-10-31 2009-05-07 Nissan Chemical Industries, Ltd. Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
DE102007061963A1 (de) * 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
CN101537006B (zh) * 2008-03-18 2012-06-06 中国科学院上海药物研究所 哒嗪酮类化合物在制备抗肿瘤药物中的用途
DE102008019907A1 (de) * 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
EP2328586A2 (en) * 2008-05-20 2011-06-08 Cephalon, Inc. Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
DE102008028905A1 (de) * 2008-06-18 2009-12-24 Merck Patent Gmbh 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
CA2729993A1 (en) * 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
US20120028988A1 (en) * 2009-03-30 2012-02-02 Sumitomo Chemical Company, Limited Use of pyridazinone compound for control of harmful arthropod pests
AR082590A1 (es) * 2010-08-12 2012-12-19 Hoffmann La Roche Inhibidores de la tirosina-quinasa de bruton

Similar Documents

Publication Publication Date Title
JP2010536719A5 (cg-RX-API-DMAC7.html)
JP2010532774A5 (cg-RX-API-DMAC7.html)
JP2011529033A5 (cg-RX-API-DMAC7.html)
RU2013134359A (ru) Комбинированная терапия с применением индуктора и ингибитора аутофагии для лечения новообразований
JP2011516501A5 (cg-RX-API-DMAC7.html)
RU2014128513A (ru) Раковый маркер и терапевтическая мишень
HRP20211652T1 (hr) Pirimidopirimidinoni korisni kao inhibitor wee-1 kinaze
TN2011000240A1 (en) Hsp90 inhibitors for therapeutic treatment
JP2021502358A5 (cg-RX-API-DMAC7.html)
RU2017124371A (ru) Комбинация производного 6-оксо-1,6-дигидро-пиридазина, обладающего противораковой активностью, с производным хиназолина
MX2009007610A (es) Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.
HRP20130549T4 (hr) Spojevi i njihove soli specifični za ppar receptore i egf receptore te njihova primjena u području medicine
JP2017536397A5 (cg-RX-API-DMAC7.html)
JP2013537228A5 (cg-RX-API-DMAC7.html)
Satou et al. Treatment of superficial carcinoma in hypopharynx
CN114349807A (zh) 一种唾液酸连接吲哚菁绿Sia-ICG及其制备方法和应用
MX2010003988A (es) Compuesto de isoxazol para el tratamiento de cancer.
RU2017124612A (ru) Комбинация производного 6-оксо-1, 6-дигидро-пиридазона, обладающего противораковой активностью, с ингибитором рэфр
WO2001079557A3 (en) Gtp-binding protein useful in treatment and detection of cancer
RU2015117550A (ru) Комбинация производного 6-оксо-1,6-дигидро-пиридазина, имеющего противораковую активность, с мек ингибитором
JP2011520996A5 (cg-RX-API-DMAC7.html)
RU2016132400A (ru) Комбинация производного 6-оксо-1,6-дигидро-пиридазина, имеющего противораковую активность, с гефитинибом
RU2021130476A (ru) Соединения имидазолонилхинолина и их терапевтическое применение
RU2022125791A (ru) Комбинации конъюгата анти-her2-антитело-лекарственное средство и химиотерапевтических средств и способы применения
Ulmeanu et al. Airways Tumors And Endoscopic Electrocautery-Curative And Palliative Benefits